GLOBAL GENITOURINARY DRUGS MARKET 2011-2015 TechNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 20112015. To Browse This Report Click : http://www.marketresearchreports.biz/analysis/147925
DESCRIPTION TechNavio's analysts forecast the Global Genitourinary Drugs market to grow at a CAGR of 3.05 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel biological drugs. The Global Genitourinary Drugs market has also been witnessing a paradigm shift toward biological drugs. However, lack of adherence to medication could pose a challenge to the growth of this market. TechNavio's report, the Global Genitourinary Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Genitourinary Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this space are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Eli Lilly and Co., GlaxoSmithKline plc, Merck and Co. Inc., and Pfizer Inc.
Other vendors mentioned in the report are Agile Therapeutics Inc., Allergan Inc., Antares Pharma Inc., Boehringer Ingelheim GmbH, Dong-A Pharmaceutical Co. Ltd., Detrol LA, Ferring Holding S.A., Kissei Pharmaceutical Co. Ltd., Merck Serono S.A., Novartis International AG, Novo Nordisk A/S, Nymox Pharmaceutical Corp., PregLem S.A., Recordati S.p.A., Rottapharm S.p.A., Teva Pharmaceutical Industries Ltd., VIVUS Inc., Warner Chilcott plc, and Watson Pharmaceuticals Inc.
KEY QUESTIONS ANSWERED IN THIS REPORT
•
What will the market size be in 2015 and what will the growth rate be?
•
What are the key market trends?
•
What is driving this market?
•
What are the challenges to market growth?
•
Who are the key vendors in this market space?
•
What are the market opportunities and threats faced by the key vendors?
•
What are the strengths and weaknesses of the key vendors?
TABLE OF CONTENT •
1. Executive Summar
•
2. Introduction
•
3. Market Coverage
•
Market Overview
•
Key Products
•
4. Market Landscape
•
4.1 Global Genitourinary Drugs Market
•
Market Size
•
Market Forecast
•
4.2 Genitourinary Drugs Market in the US
•
Market Size
•
Market Forecast
•
4.3 Genitourinary Drugs Market in Japan
•
Market Size
•
Market Forecast
•
4.4 Key Market Segmentation
•
Hormonal Contraception
•
BPH
•
Erectile Dysfunction
•
Urinary Incontinence
•
Infertility
•
Infection
•
4.5 Five Forces Analysis
•
5. Geographical Segmentation
•
6. Key Leading Countries
•
US
•
Japan
•
Germany
•
7. Vendor Landscape
•
8. Buying Criteria
•
9. Market Growth Drivers
•
10. Drivers and their Impact
•
11. Market Challenges
•
12. Impact of Drivers and Challenges
•
13. Market Trends
•
14. Key Vendor Analysis
•
14.1 Pfizer Inc.
•
Business Overview
•
SWOT Analysis
•
14.2 Bayer AG
•
Business Overview
•
SWOT Analysis
•
14.3 Eli Lilly and Co.
•
Business Overview
•
SWOT Analysis
14.4 Merck and Co. Inc. •
Business Overview
•
SWOT Analysis
•
14.5 Astellas Pharma Inc.
•
Business Overview
•
SWOT Analysis
•
14.6 GlaxoSmithKline plc
•
Business Overview
•
SWOT Analysis
•
14.7 Abbott Laboratories
•
Business Overview
•
SWOT Analysis
We are a one stop solution for all your research needs.
CONTACT INFORMATION To Browse This Report: Click Below Link
http://www.marketresearchreports.biz/analysis/147925
To Browse All Reports of this Publisher : Click Below Link
http://www.marketresearchreports.biz/publisher/73
To Browse All Reports : Visit
http://www.marketresearchreports.biz/